Join us on Saturday 26th February for a day filled with guest speaker talks & panel discussions about how artificial intelligence is changing drug discovery. We'll be hearing from scientists Founders and CEOs alike to hear both about the technical and commercial side of this new and exciting industry. There will also be opportunities for networking too! Please note that this is a virtual event.

Confirmed speakers:

• Prof Michael Bronstein: DeepMind Professor of AI @ Oxford, Head of Graph ML @ Twitter, Scientific Advisor @ Relation Therapeutics
• Prof Andreas Bender: Professor for Molecular Informatics @ Cambridge, CTO/Co-founder @ Terra Lumina
• Prof Andres Floto: Co-director @ Cambridge Centre for AI in Medicine, Director @ UK Cystic Fibrosis Innovation Hub, Professor of Respiratory Biology @ Cambridge
• Dr Petar Veličković: Staff Research Scientist @ DeepMind, Affiliated Lecturer @ Cambridge
• Dr Neel Madhukar: CEO/Founder @ OneThree Biotech
• Dr Daniel Jamieson FRSB: CEO/Founder @ Biorelate
• Dr Rabia Khan: CEO/Founder @ LadderTx

Additional panellists:

• Prof Sir Tom Blundell: Sir William Dunn Professor of Biochemistry and Chairman of the Council of Biological Sciences @ Cambridge
• Dr Nathan Benaich: Founder and General Partner @ AirStreet Capital, Co-auothor of State of AI report
• Laksh Aithani: CEO/Founder @ CHARMTx